These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 27213235)
41. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart. Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380 [TBL] [Abstract][Full Text] [Related]
42. O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter? Lima VV; Spitler K; Choi H; Webb RC; Tostes RC Clin Sci (Lond); 2012 Oct; 123(8):473-86. PubMed ID: 22757958 [TBL] [Abstract][Full Text] [Related]
43. A novel strategy for global mapping of O-GlcNAc proteins and peptides using selective enzymatic deglycosylation, HILIC enrichment and mass spectrometry identification. Shen B; Zhang W; Shi Z; Tian F; Deng Y; Sun C; Wang G; Qin W; Qian X Talanta; 2017 Jul; 169():195-202. PubMed ID: 28411811 [TBL] [Abstract][Full Text] [Related]
44. Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker(s) for diabetes. Wang Z; Park K; Comer F; Hsieh-Wilson LC; Saudek CD; Hart GW Diabetes; 2009 Feb; 58(2):309-17. PubMed ID: 18984734 [TBL] [Abstract][Full Text] [Related]
45. Effects of O-GlcNAcylation on functional mitochondrial transfer from astrocytes. Park JH; Nakamura Y; Li W; Hamanaka G; Arai K; Lo EH; Hayakawa K J Cereb Blood Flow Metab; 2021 Jul; 41(7):1523-1535. PubMed ID: 33153373 [TBL] [Abstract][Full Text] [Related]
46. Minireview series on the thirtieth anniversary of research on O-GlcNAcylation of nuclear and cytoplasmic proteins: Nutrient regulation of cellular metabolism and physiology by O-GlcNAcylation. Hart GW J Biol Chem; 2014 Dec; 289(50):34422-3. PubMed ID: 25336646 [TBL] [Abstract][Full Text] [Related]
47. Enhancement of Xu H; Du M; Shen Y; Yang Y; Ding F; Yu S Molecules; 2021 Sep; 26(19):. PubMed ID: 34641427 [No Abstract] [Full Text] [Related]
48. Exercise and diabetes have opposite effects on the assembly and O-GlcNAc modification of the mSin3A/HDAC1/2 complex in the heart. Cox EJ; Marsh SA Cardiovasc Diabetol; 2013 Jul; 12():101. PubMed ID: 23835259 [TBL] [Abstract][Full Text] [Related]
49. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins. Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592 [TBL] [Abstract][Full Text] [Related]
50. Roles of O-GlcNAc in chronic diseases of aging. Banerjee PS; Lagerlöf O; Hart GW Mol Aspects Med; 2016 Oct; 51():1-15. PubMed ID: 27259471 [TBL] [Abstract][Full Text] [Related]
51. Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein Chen Y; Zhao X; Wu H Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1911-1924. PubMed ID: 31462094 [TBL] [Abstract][Full Text] [Related]
52. Quantitative analysis of O-GlcNAcylation in combination with isobaric tag labeling and chemoenzymatic enrichment. Tsumoto H; Akimoto Y; Endo T; Miura Y Bioorg Med Chem Lett; 2017 Nov; 27(22):5022-5026. PubMed ID: 29029932 [TBL] [Abstract][Full Text] [Related]
53. Proteomic approaches for site-specific O-GlcNAcylation analysis. Wang S; Yang F; Camp DG; Rodland K; Qian WJ; Liu T; Smith RD Bioanalysis; 2014; 6(19):2571-80. PubMed ID: 25411699 [TBL] [Abstract][Full Text] [Related]
54. Exploring leukocyte O-GlcNAcylation as a novel diagnostic tool for the earlier detection of type 2 diabetes mellitus. Springhorn C; Matsha TE; Erasmus RT; Essop MF J Clin Endocrinol Metab; 2012 Dec; 97(12):4640-9. PubMed ID: 23066116 [TBL] [Abstract][Full Text] [Related]
55. Increased O-GlcNAcylation of NF-κB Enhances Retinal Ganglion Cell Death in Streptozotocin-induced Diabetic Retinopathy. Kim SJ; Yoo WS; Choi M; Chung I; Yoo JM; Choi WS Curr Eye Res; 2016; 41(2):249-57. PubMed ID: 25835259 [TBL] [Abstract][Full Text] [Related]
56. Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy. Fricovsky ES; Suarez J; Ihm SH; Scott BT; Suarez-Ramirez JA; Banerjee I; Torres-Gonzalez M; Wang H; Ellrott I; Maya-Ramos L; Villarreal F; Dillmann WH Am J Physiol Regul Integr Comp Physiol; 2012 Oct; 303(7):R689-99. PubMed ID: 22874425 [TBL] [Abstract][Full Text] [Related]
57. A chemical glycoproteomics platform reveals O-GlcNAcylation of mitochondrial voltage-dependent anion channel 2. Palaniappan KK; Hangauer MJ; Smith TJ; Smart BP; Pitcher AA; Cheng EH; Bertozzi CR; Boyce M Cell Rep; 2013 Oct; 5(2):546-52. PubMed ID: 24120863 [TBL] [Abstract][Full Text] [Related]
58. dbOGAP - an integrated bioinformatics resource for protein O-GlcNAcylation. Wang J; Torii M; Liu H; Hart GW; Hu ZZ BMC Bioinformatics; 2011 Apr; 12():91. PubMed ID: 21466708 [TBL] [Abstract][Full Text] [Related]
59. Proteomic analysis of O-GlcNAcylated proteins in invasive ductal breast carcinomas with and without lymph node metastasis. Jiang K; Gao Y; Hou W; Tian F; Ying W; Li L; Bai B; Hou G; Wang PG; Zhang L Amino Acids; 2016 Feb; 48(2):365-74. PubMed ID: 26374642 [TBL] [Abstract][Full Text] [Related]
60. Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart. Pham T; Loiselle D; Power A; Hickey AJ Am J Physiol Cell Physiol; 2014 Sep; 307(6):C499-507. PubMed ID: 24920675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]